The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.
Nov 8, 2023
0
0
Spend some time scrolling social media and you're all-but-guaranteed to see an ad promising to help you with targeted fat loss. These ads promote a concept known as "spot reduction," claiming you can burn fat in a specific ...
Nov 1, 2023
0
11
Inflammation is a risk factor for many chronic diseases, including cardiovascular disease (CVD), and the impact of diet on inflammation is an area of growing scientific interest. In particular, recommendations to limit red ...
Oct 26, 2023
0
104
Patients with previous bariatric surgery who undergo body contouring (BC) regain more weight at long-term follow-up, compared to BC patients who did not have bariatric surgery, reports a study in Plastic and Reconstructive ...
Oct 24, 2023
0
0
Female offspring of parents with mood disorders have increased z body mass index (BMI) compared with controls of unaffected parents starting at about 12 years of age, according to a study published online Oct. 19 in JAMA ...
Oct 20, 2023
0
0
The effects of prolonged screen use during childhood have been extensively studied in recent years. Evidence indicates that excessive screen time is harmful both to neurological development and socialization. This is because, ...
Oct 19, 2023
0
0
Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests thesedrugs may be less effective in women who are obese.
Oct 18, 2023
0
1
Psychology researchers from the University of Liverpool have conducted a long-term study to understand the effect of artificially sweetened drinks on weight management.
Oct 16, 2023
0
0
The number of hours of light exposure we experience affects how we eat and how we burn energy. This may help us understand the link between seasons and metabolism.
Oct 16, 2023
0
57
After 12 initial weeks of weight loss with intensive lifestyle intervention alone, participants in the SURMOUNT-3 study who were randomly assigned to tirzepatide for 72 weeks achieved a total mean reduction in baseline body ...
Oct 16, 2023
0
30
